Perceptive is a global technology-enabled service provider serving the pharmaceutical and biotech industries. The company operates across the preclinical and clinical trial lifecycle, with particular focus on imaging and interactive response technologies. Its expertise spans radiochemistry, in vivo imaging, cloud-based randomization and trial supply management platforms, electronic clinical outcome assessments, and independent imaging core laboratory services.
The firm organises its operations around three main service lines. Perceptive Discovery offers preclinical and translational imaging services including radiochemistry and in vivo imaging. Perceptive eClinical provides cloud-based randomization and trial supply management platforms along with electronic clinical outcome assessments. Perceptive Imaging functions as an independent imaging core laboratory for clinical trials worldwide.
Perceptive combines over 50 years of specialised experience across these domains, having supported nearly 12,000 clinical trials and contributed to over 800 regulatory approvals. The company maintains a presence in the US, Europe, the UK, and Asia, and works across therapeutic areas including oncology, neuroscience, radiopharmaceutical therapy, and rare diseases. It offers 24/7 service delivery to its clients, which include pharmaceutical companies, biotech firms, and clinical research organisations. Founded in 2024, Perceptive operates as a unified entity bringing together established capabilities in trial imaging and supply management.
